-
Something wrong with this record ?
Angiopoietin-like protein 6 in patients with obesity, type 2 diabetes mellitus, and anorexia nervosa: The influence of very low-calorie diet, bariatric surgery, and partial realimentation
A. Cinkajzlova, Z. Lacinova, J. Klouckova, P. Kavalkova, P. Trachta, M. Kosak, D. Haluzikova, H. Papezova, M. Mraz, M. Haluzík,
Language English Country England, Great Britain
Document type Journal Article
Grant support
NT13299
MZ0
CEP Register
NV15-26854A
MZ0
CEP Register
NV15-27863A
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Full text - Article
Source
Source
Source
NLK
Medline Complete (EBSCOhost)
from 2001-02-01
- MeSH
- Angiopoietins blood MeSH
- Bariatric Surgery MeSH
- Diabetes Mellitus, Type 2 blood diet therapy surgery MeSH
- Caloric Restriction MeSH
- Middle Aged MeSH
- Humans MeSH
- Anorexia Nervosa blood diet therapy metabolism MeSH
- Obesity blood diet therapy surgery MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
AIM OF THE STUDY: Angiopoietin-like protein 6 (ANGPTL6) is a circulating protein with a potential role in energy homeostasis. The aim of the study was to explore the changes in ANGPTL6 levels in patients with obesity (Body mass index, BMI > 40 kg/m(2)) with and without type 2 diabetes mellitus (T2DM) undergoing dietary intervention (very low calorie diet - VLCD) and in a subgroup of T2DM patients after bariatric surgery. Additionally, we examined changes in ANGPTL6 in anorexia nervosa (AN) patients at baseline and after partial realimentation. We also explored the changes in ANGPTL6 mRNA expression in subcutaneous adipose tissue (SAT) of obese subjects. MATERIALS AND METHODS: The study included 23 non-diabetic obese patients, 40 obese patients with T2DM (27 underwent VLCD and 13 underwent bariatric surgery), 22 patients with AN, and 37 healthy control subjects. RESULTS: ANGPTL6 levels of AN patients were increased relative to the control group (68.6 ± 9.9 ng/ml) and decreased from 110.2 ± 13.3 to 73.6 ± 7.1 ng/ml (p = 0.004) after partial realimentation. Baseline ANGPTL6 levels in patients with obesity and T2DM did not differ from the control group. VLCD decreased ANGPTL6 levels only in obese patients with T2DM. Bariatric surgery induced a transient elevation of ANGPTL6 levels with a subsequent decrease to baseline levels. ANGPTL6 mRNA expression transiently increased after bariatric surgery and returned to baseline levels after 12 months. CONCLUSIONS: Collectively, our data suggest that serum ANGPTL6 levels and ANGPTL6 mRNA expression in SAT are affected by metabolic disorders and their treatment but do not appear to directly reflect nutritional status.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013896
- 003
- CZ-PrNML
- 005
- 20201019162716.0
- 007
- ta
- 008
- 170413s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/07435800.2016.1169544 $2 doi
- 035 __
- $a (PubMed)27135654
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Cinkajzlová, Anna $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0228108
- 245 10
- $a Angiopoietin-like protein 6 in patients with obesity, type 2 diabetes mellitus, and anorexia nervosa: The influence of very low-calorie diet, bariatric surgery, and partial realimentation / $c A. Cinkajzlova, Z. Lacinova, J. Klouckova, P. Kavalkova, P. Trachta, M. Kosak, D. Haluzikova, H. Papezova, M. Mraz, M. Haluzík,
- 520 9_
- $a AIM OF THE STUDY: Angiopoietin-like protein 6 (ANGPTL6) is a circulating protein with a potential role in energy homeostasis. The aim of the study was to explore the changes in ANGPTL6 levels in patients with obesity (Body mass index, BMI > 40 kg/m(2)) with and without type 2 diabetes mellitus (T2DM) undergoing dietary intervention (very low calorie diet - VLCD) and in a subgroup of T2DM patients after bariatric surgery. Additionally, we examined changes in ANGPTL6 in anorexia nervosa (AN) patients at baseline and after partial realimentation. We also explored the changes in ANGPTL6 mRNA expression in subcutaneous adipose tissue (SAT) of obese subjects. MATERIALS AND METHODS: The study included 23 non-diabetic obese patients, 40 obese patients with T2DM (27 underwent VLCD and 13 underwent bariatric surgery), 22 patients with AN, and 37 healthy control subjects. RESULTS: ANGPTL6 levels of AN patients were increased relative to the control group (68.6 ± 9.9 ng/ml) and decreased from 110.2 ± 13.3 to 73.6 ± 7.1 ng/ml (p = 0.004) after partial realimentation. Baseline ANGPTL6 levels in patients with obesity and T2DM did not differ from the control group. VLCD decreased ANGPTL6 levels only in obese patients with T2DM. Bariatric surgery induced a transient elevation of ANGPTL6 levels with a subsequent decrease to baseline levels. ANGPTL6 mRNA expression transiently increased after bariatric surgery and returned to baseline levels after 12 months. CONCLUSIONS: Collectively, our data suggest that serum ANGPTL6 levels and ANGPTL6 mRNA expression in SAT are affected by metabolic disorders and their treatment but do not appear to directly reflect nutritional status.
- 650 _2
- $a angiopoetiny $x krev $7 D042682
- 650 _2
- $a mentální anorexie $x krev $x dietoterapie $x metabolismus $7 D000856
- 650 _2
- $a bariatrická chirurgie $7 D050110
- 650 _2
- $a kalorická restrikce $7 D031204
- 650 _2
- $a diabetes mellitus 2. typu $x krev $x dietoterapie $x chirurgie $7 D003924
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a obezita $x krev $x dietoterapie $x chirurgie $7 D009765
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lacinová, Zdeňka $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. b Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0062138
- 700 1_
- $a Kloučková, Jana $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0232313
- 700 1_
- $a Kaválková, Petra $u a Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0094376
- 700 1_
- $a Trachta, Pavel $u Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0248280
- 700 1_
- $a Kosák, Mikuláš $u Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0105672
- 700 1_
- $a Haluzíková, Denisa, $u c Department of Sports Medicine, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $d 1970- $7 jo2003163140
- 700 1_
- $a Papežová, Hana, $u Department of Psychiatry, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $d 1953- $7 jn20001005414
- 700 1_
- $a Mráz, Miloš $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. b Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic. $7 xx0119173
- 700 1_
- $a Haluzík, Martin, $u Department of Obesitology , Institute of Endocrinology , Prague , Czech Republic. $d 1970- $7 xx0000707
- 773 0_
- $w MED00001519 $t Endocrine research $x 1532-4206 $g Roč. 42, č. 1 (2017), s. 22-30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27135654 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20201019162715 $b ABA008
- 999 __
- $a ok $b bmc $g 1200361 $s 974674
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 42 $c 1 $d 22-30 $e 20160502 $i 1532-4206 $m Endocrine research $n Endocr Res $x MED00001519
- GRA __
- $a NT13299 $p MZ0
- GRA __
- $a NV15-26854A $p MZ0
- GRA __
- $a NV15-27863A $p MZ0
- LZP __
- $a Pubmed-20170413